Risk of breast cancer in post-menopausal women using hormone replacement therapy

Journal of the Medical Association of Thailand

Volumn 85, Issue 5, 2002, Pages 583-589

  Ratanawichitrasin, Adune ^a   Reansuwan, Woramin ^a   Ratanawichitrasin, Somsri ^a   Bhodhisuwan, Kris ^a   Kongpatanakul, Supornchai ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST TUMOR; CASE CONTROL STUDY; FEMALE; HORMONE SUBSTITUTION; HUMAN; MIDDLE AGED; RISK FACTOR; STATISTICAL MODEL; THAILAND;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; LOGISTIC MODELS; MIDDLE AGED; RISK FACTORS; THAILAND;

EID: 0036562043     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Henderson BE, Paganini-Hill A, Ross RK. Decreased mortality in users of estrogen replacement therapy. Arch Intern Med 1991; 151: 75-8.
2. Stamfer MJ, Colditz GA, Willett WC, et al. Post-menopausal estrogen therapy and cardiovascular disease : Ten-year follow-up from the Nurses' Health Study. N Engl J Med 1991; 325: 756-62.
3. Sullivan JM, Vander Zwaag R, et al. Estrogen therapy and coronary artery disease. Effect on survival in post-menopausal women. Arch Intern Med 1990; 150: 2557-62.
4. Lindsay R, Tohme JF. Estrogen treatment of patients with established post-menopausal osteoporosis. Obstet Gynecol 1990; 76: 290-5.
5. Prior JC, Vigna YM, Barr SI, Rexworthy C, Lentle BC. Cyclic medroxyprogesterone treatment increases bone density: A controlled trial in active women with menstrual cycle disturbances. Am J Med 1994; 96: 521-30.
6. Persson I, Adami HO, Bergkvist L, et al. Risk of endometrial cancer after treatment with estrogen alone or in conjunction with progestogens: Results of prospective study. BMJ 1989; 298: 157-51.
7. Leather AT, Savas M, Studd JW. Endometrial histology and bleeding pattern after 8 years of continuous combined estrogen and progesterone therapy in post-menopausal women. Obstet Gynecol 1991; 78: 1008-10.
8. Colditz GA, Hankinson SE, Hunter AJ, et al. The use of estrogens and progestins and the risk of breast cancer in post-menopausal women. N Engl J Med 1995; 332: 1589-93.
9. Sillero-Arenas M, Delgado-Rodriguez M, Rodigues-Canteras R, Bueno-Cavanillas A, Galvez-Vargas R. Menopausal hormonal replacement therapy and breast cancer: A meta-analysis. Obstet Gynecol 1992; 79: 286-94.
10. Steinberg KK, Thacker SB, Smith SJ, et al. A metaanalysis of the effect of estrogen replacement therapy on the risk of breast cancer. JAMA 1991; 265: 1985-90.
11. Dever M, Barrett-Connor E, Ren vail M, Feigal D Jr, Ramsdell J. Estrogen replacement therapy and the risk of venous thrombosis. Am J Med 1992; 92: 275-82.
12. Dupont WD, Page DL. Menopausal estrogen replacement therapy and breast cancer. Arch Intern Med 1991; 151: 67-72.
13. Armstrong BK. Estrogen therapy after the menopause-boon or bane? Med J Aust 1988; 148: 213-4.
14. Steinberg KK., Smith SJ, Thacker SB, Stroup DF. Breast cancer risk and duration of estrogen use: The role of study design in meta-analysis. Epidemiology 1994; 5: 415-21.
15. Silva I. Cancer epidemiology: Principles and methods. Lyon, France: IARC, 1999: 355-84.